Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8110674 Therapeutic compositions

Patent 8110674 was granted and assigned to Alnylam Pharmaceuticals on February, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Date Filed
March 8, 2004
0
Date of Patent
February 7, 2012
0
Patent Application Number
10548611
0
Patent Citations Received
‌
US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease
0
‌
US Patent 11859184 Multi-conjugate of siRNA and preparing method thereof
0
‌
US Patent 11873490 Antisense oligomers for treatment of conditions and diseases
0
‌
US Patent 11891605 Reducing intron retention
0
‌
US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
0
‌
US Patent 12005074 Extrahepatic delivery
0
‌
US Patent 11667915 RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
0
‌
US Patent 11767531 Defined multi-conjugates oligonucleotides
Patent Inventor Names
David Bumcrot
0
Muthiah Manoharan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8110674
0
Patent Primary Examiner
‌
Tracy Vivlemore
0

Find more entities like US Patent 8110674 Therapeutic compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.